NTRA Quote, Financials, Valuation and Earnings

Delcath Systems has a net margin of -7.18% compared to Natera's net margin of 16.64%. Natera's return on equity of -26.45% beat Delcath Systems's return on equity of -251.36%.

Natera has a consensus price target of $167.90, signalling upside risk potential of 3.39%. On the other hand Delcath Systems has an analysts' consensus of -- which suggests that it could grow by 88.13%. Given that Delcath Systems has higher upside potential than Natera, analysts believe Delcath Systems is more attractive than Natera.

Natera has a beta of 1.628, which suggesting that the stock is 62.789% more volatile than S&P 500. In comparison Delcath Systems has a beta of 0.851, suggesting its less volatile than the S&P 500 by 14.882%.

Natera has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera pays -- of its earnings as a dividend. Delcath Systems pays out -- of its earnings as a dividend.

Natera quarterly revenues are $439.8M, which are larger than Delcath Systems quarterly revenues of $11.2M. Natera's net income of -$31.6M is lower than Delcath Systems's net income of $1.9M. Notably, Natera's price-to-earnings ratio is -- while Delcath Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera is 12.90x versus 13.59x for Delcath Systems. Usually stocks with elevated PS ratios are considered overvalued.

Guardant Health has a net margin of -7.18% compared to Natera's net margin of -56.28%. Natera's return on equity of -26.45% beat Guardant Health's return on equity of -651%.

Natera has a consensus price target of $167.90, signalling upside risk potential of 3.39%. On the other hand Guardant Health has an analysts' consensus of $42.30 which suggests that it could grow by 36.84%. Given that Guardant Health has higher upside potential than Natera, analysts believe Guardant Health is more attractive than Natera.

Natera has a beta of 1.628, which suggesting that the stock is 62.789% more volatile than S&P 500. In comparison Guardant Health has a beta of 1.255, suggesting its more volatile than the S&P 500 by 25.526%.

Natera has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Guardant Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera pays -- of its earnings as a dividend. Guardant Health pays out -- of its earnings as a dividend.

Natera quarterly revenues are $439.8M, which are larger than Guardant Health quarterly revenues of $191.5M. Natera's net income of -$31.6M is higher than Guardant Health's net income of -$107.8M. Notably, Natera's price-to-earnings ratio is -- while Guardant Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera is 12.90x versus 5.54x for Guardant Health. Usually stocks with elevated PS ratios are considered overvalued.

Progyny has a net margin of -7.18% compared to Natera's net margin of 3.64%. Natera's return on equity of -26.45% beat Progyny's return on equity of 11.31%.

Natera has a consensus price target of $167.90, signalling upside risk potential of 3.39%. On the other hand Progyny has an analysts' consensus of $30.22 which suggests that it could grow by 29.78%. Given that Progyny has higher upside potential than Natera, analysts believe Progyny is more attractive than Natera.

Natera has a beta of 1.628, which suggesting that the stock is 62.789% more volatile than S&P 500. In comparison Progyny has a beta of 1.350, suggesting its more volatile than the S&P 500 by 34.952%.

Natera has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Progyny offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera pays -- of its earnings as a dividend. Progyny pays out -- of its earnings as a dividend.

Natera quarterly revenues are $439.8M, which are larger than Progyny quarterly revenues of $286.6M. Natera's net income of -$31.6M is lower than Progyny's net income of $10.4M. Notably, Natera's price-to-earnings ratio is -- while Progyny's PE ratio is 25.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera is 12.90x versus 1.26x for Progyny. Usually stocks with elevated PS ratios are considered overvalued.

Star Equity Holdings has a net margin of -7.18% compared to Natera's net margin of -14.42%. Natera's return on equity of -26.45% beat Star Equity Holdings's return on equity of -10.13%.

Natera has a consensus price target of $167.90, signalling upside risk potential of 3.39%. On the other hand Star Equity Holdings has an analysts' consensus of -- which suggests that it could grow by 380.77%. Given that Star Equity Holdings has higher upside potential than Natera, analysts believe Star Equity Holdings is more attractive than Natera.

Natera has a beta of 1.628, which suggesting that the stock is 62.789% more volatile than S&P 500. In comparison Star Equity Holdings has a beta of 0.080, suggesting its less volatile than the S&P 500 by 91.951%.

Natera has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Star Equity Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera pays -- of its earnings as a dividend. Star Equity Holdings pays out 7.62% of its earnings as a dividend. Star Equity Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Natera quarterly revenues are $439.8M, which are larger than Star Equity Holdings quarterly revenues of $13.7M. Natera's net income of -$31.6M is lower than Star Equity Holdings's net income of -$2M. Notably, Natera's price-to-earnings ratio is -- while Star Equity Holdings's PE ratio is 0.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera is 12.90x versus 0.13x for Star Equity Holdings. Usually stocks with elevated PS ratios are considered overvalued.